Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBBYNASDAQ:NVAXNASDAQ:WKME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBBYBed Bath & Beyond$0.08$0.13$0.07▼$30.00$33.78M1.49122.76 million shs8.82 million shsNVAXNovavax$7.29+2.5%$6.63$5.01▼$23.86$1.18B3.217.31 million shs7.10 million shsWKMEWalkMe$13.95$13.90$7.60▼$14.09$1.21B0.16438,095 shsN/AFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBBYBed Bath & Beyond0.00%0.00%0.00%0.00%0.00%NVAXNovavax+2.53%+15.90%+16.64%-8.76%-53.57%WKMEWalkMe0.00%0.00%0.00%0.00%+63.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBBYBed Bath & Beyond0.473 of 5 stars0.00.00.02.40.01.71.3NVAXNovavax3.7207 of 5 stars3.21.00.04.73.80.80.6WKMEWalkMeN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBBYBed Bath & Beyond 0.00N/AN/AN/ANVAXNovavax 2.43Hold$19.00160.63% UpsideWKMEWalkMe 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest BBBY, NVAX, and WKME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025NVAXNovavaxB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/9/2025NVAXNovavaxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$9.00 ➝ $7.002/28/2025NVAXNovavaxBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$19.002/27/2025NVAXNovavaxTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 5/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBBYBed Bath & Beyond$6.21B0.01$1.97 per share0.04$2.18 per share0.04NVAXNovavax$1.21B0.97N/AN/A($6.04) per share-1.21WKMEWalkMe$266.95M4.53N/AN/A$3.00 per share4.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBBYBed Bath & Beyond-$559.62M-$15.20N/AN/AN/A-20.54%N/A-18.68%N/ANVAXNovavax-$545.06M$2.65N/A91.132.85-32.18%N/A-17.05%N/AWKMEWalkMe-$59.14M-$0.44N/A∞N/A-16.55%-9.60%-5.43%N/ALatest BBBY, NVAX, and WKME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025NVAXNovavax$0.71$2.93+$2.22$2.93$204.08 million$666.66 million2/27/2025Q4 2024NVAXNovavax-$0.75-$0.51+$0.24-$0.51$85.48 million$88.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBBYBed Bath & Beyond$0.68861.85%N/AN/A N/ANVAXNovavaxN/AN/AN/AN/AN/AWKMEWalkMeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBBYBed Bath & BeyondN/A0.730.17NVAXNovavaxN/A0.930.93WKMEWalkMeN/A2.042.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBBYBed Bath & Beyond64.16%NVAXNovavax53.04%WKMEWalkMe70.91%Insider OwnershipCompanyInsider OwnershipBBBYBed Bath & Beyond1.70%NVAXNovavax1.00%WKMEWalkMe27.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBBYBed Bath & Beyond32,000428.10 million420.82 millionOptionableNVAXNovavax1,990161.97 million158.58 millionOptionableWKMEWalkMe1,21086.78 million62.86 millionOptionableBBBY, NVAX, and WKME HeadlinesRecent News About These CompaniesABeam Consulting Partners with WalkMe to Enhance Enterprise Management Services in Southeast AsiaApril 10, 2025 | businesswire.comCategory Creator WalkMe Recognized As The “AI-Powered DAP for the Enterprise” In Industry Analyst ReportNovember 26, 2024 | globenewswire.com3 Global Stocks to Diversify Your PortfolioOctober 25, 2024 | stocknews.comWalkMe Inc.: SAP Completes Acquisition of WalkMeSeptember 13, 2024 | finanznachrichten.deSAP Closes Acquisition Of WalkMeSeptember 13, 2024 | markets.businessinsider.comWhere are the Opportunities in (WKME)September 13, 2024 | news.stocktradersdaily.comSAP Completes Acquisition of WalkMeSeptember 12, 2024 | globenewswire.com(WKME) Investment ReportAugust 28, 2024 | news.stocktradersdaily.comWalkMe Doubles Down on AI Innovation, Releases Enhancements to Award-Winning Copilot, WalkMe(X)August 19, 2024 | globenewswire.comIsraeli software firm WalkMe to sublease space from Salesforce for U.S. HQAugust 16, 2024 | bizjournals.comNeedham Reaffirms Their Hold Rating on WalkMe (WKME)August 6, 2024 | markets.businessinsider.comCatalyst Watch: Disney earnings, Costco sales update, MicroStrategy split, and eyes on AI patentsAugust 3, 2024 | msn.comWalkMe Ltd Ordinary SharesAugust 3, 2024 | morningstar.comWKME Stock Earnings: WalkMe Beats EPS, Misses Revenue for Q2 2024August 2, 2024 | investorplace.comWalkMe Inc.: WalkMe Ltd. Announces Second Quarter 2024 Financial ResultsAugust 2, 2024 | finanznachrichten.deArgus upgrades SAP to 'Buy' with target price of $240August 2, 2024 | msn.comWalkMe Ltd. Announces Second Quarter 2024 Financial ResultsAugust 1, 2024 | globenewswire.comTrading (WKME) With Integrated Risk ControlsJuly 25, 2024 | news.stocktradersdaily.comDigital Adoption Professionals Emerge as Key Players in AI Transformation, New WalkMe Survey RevealsJuly 25, 2024 | globenewswire.comWalkMe Celebrates Winners of Annual Realizer AwardsJuly 2, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBBY, NVAX, and WKME Company DescriptionsBed Bath & Beyond NASDAQ:BBBYBed Bath & Beyond, Inc. engages in the operation of retail stores and retails domestics merchandise and home furnishings. Its products include domestic merchandise and home furnishings such as bed linens and related items, bath items, kitchen textiles, kitchen and tabletop items, fine tabletop, basic house wares, general home furnishings, and consumables. The company was founded by Warren Eisenberg and Leonard Feinstein in 1971 and is headquartered in Union, NJ.Novavax NASDAQ:NVAX$7.29 +0.18 (+2.53%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$7.28 -0.01 (-0.14%) As of 07:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.WalkMe NASDAQ:WKMEWalkMe Ltd. provides cloud-based digital adaption platform and associated professional services in the United States and internationally. The company's AI-driven digital adoption platform helps companies to effectively navigate change brought by technology, which stack, identifies, and delivers the personalized guidance and automation. In addition, the company WalkMe's platform is delivered via web, desktop or mobile and pre-packaged to support the key workflows. The company was formerly known as Make Tutorial Ltd. and changed its name to WalkMe Ltd. in March 2012. WalkMe Ltd. was incorporated in 2011 and is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1 Cathie Wood Just Bought a New Stake in Taiwan Semiconductor Stock Super Micro Computer Stock Clears New Path Higher on Saudi Orders Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith? Why Carnival Could Be the Ultimate Non-Tech Growth Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
